ClinicalMetric / Countries / Turkey / hemiplegia
← 🇹🇷 Turkey Trials
🇹🇷 Turkey Country × Condition

hemiplegia Clinical Trials in Turkey

Active clinical trials for hemiplegia with research sites in Turkey. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇹🇷 Turkey

Active Trials in Turkey (3)

NCT07725211
Recruiting

Task-Oriented Training Versus High-Intensity Gait Training in People With Chronic Stroke

Enrollment
45 pts
Country
🇹🇷 Turkey
Istanbul University - Cerrahpasa
View Trial →
NCT06946082
Recruiting

The Effect of Upper Extremity Motor Function, Trunk Control and Motor Imagery Ability on Turkish Language Skills in Individuals With Stroke

Enrollment
101 pts
Country
🇹🇷 Turkey
Izmir Bakircay University
View Trial →
NCT06793800
Recruiting

Effect of Transcutaneous Auricular Vagus Nerve Stimulation Application on Respiratory Functions in Stroke Patients

Enrollment
50 pts
Country
🇹🇷 Turkey
Fenerbahce University
View Trial →

Frequently Asked Questions

How many hemiplegia clinical trials are active in Turkey?
There are currently 3 active clinical trials for hemiplegia with sites in Turkey, of which 3 are actively recruiting patients.
How can I join a hemiplegia clinical trial in Turkey?
To join a hemiplegia clinical trial in Turkey, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Turkey directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are hemiplegia trials in Turkey?
Active hemiplegia trials in Turkey span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Turkey Trials → Global hemiplegia Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology